People: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

45.82USD
5 May 2015
Change (% chg)

$-0.52 (-1.12%)
Prev Close
$46.34
Open
$46.36
Day's High
$46.44
Day's Low
$45.66
Volume
2,263,478
Avg. Vol
3,497,721
52-wk High
$55.63
52-wk Low
$41.25

Search Stocks

Gent, Christopher 

Sir Christopher Charles Gent has resigned as Non-Executive Independent Chairman of the Board of GlaxoSmithKline plc., effective 7 May 2015. He has many years of experience of leading global businesses and a track record of delivering outstanding performance in highly competitive industries. He was appointed Managing Director of Vodafone plc in 1985 and then became its Chief Executive Officer in 1997 until his retirement in 2003. He is a Non-Executive Director of Ferrari SpA, a Senior Adviser at Bain & Co and a member of the British Airways International Business Advisory Board.

Basic Compensation

Total Annual Compensation, GBP Long-Term Incentive Plans, GBP All Other, GBP Fiscal Year Total, GBP
734,000 -- -- 734,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Christopher Gent

734,000

Andrew Witty

3,891,000

Philip Hampton

--

Simon Dingemans

1,850,000

Moncef Slaoui

4,333,000

Roger Connor

--
As Of  30 Dec 2014
Search Stocks